This is in line with our findings were TYMS was not overexpressed in AD where pemetrexed has a main role in treatment, but significantly overexpressed in SCLC and SQ were it has no proven effect, and is not used in the clinic (42–44). The gene discussed is TYMS; the disease is small cell lung carcinoma.